Vivos Therapeutics (VVOS) Shares Outstanding (Entity) (2019 - 2026)
Vivos Therapeutics (VVOS) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Vivos Therapeutics | 4.96 Mn | 3.16 Mn | 2.95 Mn | 14.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.49 Mn |
| Dec 31, 2025 | 9.29 Mn |
| Sep 30, 2025 | 10.96 Mn |
| Jun 30, 2025 | 7.32 Mn |
| Mar 31, 2025 | 8.60 Mn |
| Dec 31, 2024 | 5.89 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 990,562.00 |
| Dec 31, 2022 | 920.48 Mn |
| Sep 30, 2022 | 849.34 Mn |
| Jun 30, 2022 | 849.34 Mn |
| Mar 31, 2022 | 920,485.00 |
| Dec 31, 2021 | 920,485.00 |
| Sep 30, 2021 | 920,485.00 |
| Jun 30, 2021 | 912,485.00 |